Basic Information
Monrol is one of the largest nuclear medicine companies in the world, leading innovation in the research, development, and manufacturing of GMP-grade radioisotopes and radiopharmaceuticals, with its headquarters located in Istanbul. Monrol is marketing its world-class radiopharmaceutical product portfolio globally with excellence in quality. As a CDMO, Monrol provides early-stage development support to its clients and offers fully integrated services for today’s flexible, lean virtual companies, effectively transitioning new product concepts into clinical trials, demonstrating proof-of-concept, and conducting first-in-human studies. Committed to transforming and improving the journey for cancer treatment patients, Monrol’s radiopharmaceutical product portfolio is distributed across more than 50 countries worldwide.